Fundamentals Overview
Elevance Health Inc. is in the middle of its 52-week range with low valuation, trading relatively flat today.
Valuation low
Intrinsic value (DCF)
+355.2% upside vs price
Profitability
Risk (Beta)
0.5 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +355.2% upside vs price · Analyst grade: A-
Pressures (Sell):
3M vs S&P 500: -14.8%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: A-. Recent institutional grades: mixed. Current institutional positions: Buy: 9, Equal Weight: 2, Hold: 1, Neutral: 2, Outperform: 4, Overweight: 12.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $1,502.45; current price is $330.05. That’s a +355.2% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 13.87 |
| DCF value (model) | $1,502.45 (355.2% upside) |
| PEG (TTM) | N/A |
| P/B (TTM) | 1.66 |
| P/S (TTM) | 0.36 |
| P/FCF (TTM) | 11.29 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 1.48 |
| Quick Ratio (TTM) | 1.48 |
| Cash Ratio (TTM) | 0.21 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 2.62% |
| Gross margin (TTM) | 23.16% |
| Operating margin (TTM) | 3.81% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for ELV.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Jefferies | maintain | Buy | Buy | 2026-04-20 |
| Truist Securities | maintain | Buy | Buy | 2026-04-13 |
| Mizuho | maintain | Outperform | Outperform | 2026-03-11 |
| JP Morgan | maintain | Overweight | Overweight | 2026-02-02 |
| Truist Securities | maintain | Buy | Buy | 2026-02-02 |
| Barclays | maintain | Overweight | Overweight | 2026-01-30 |
| Wells Fargo | maintain | Overweight | Overweight | 2026-01-30 |
| Guggenheim | maintain | Buy | Buy | 2026-01-29 |
| Guggenheim | maintain | Buy | Buy | 2026-01-22 |
| Wolfe Research | upgrade | Peer Perform | Outperform | 2026-01-08 |
| Wells Fargo | maintain | Overweight | Overweight | 2026-01-07 |
| Barclays | maintain | Overweight | Overweight | 2026-01-05 |
| Deutsche Bank | downgrade | Buy | Hold | 2025-12-19 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-12-18 |
| TD Cowen | maintain | Buy | Buy | 2025-11-26 |
| Mizuho | maintain | Outperform | Outperform | 2025-11-04 |
| JP Morgan | maintain | Overweight | Overweight | 2025-10-28 |
| TD Cowen | maintain | Buy | Buy | 2025-10-23 |
| Barclays | maintain | Overweight | Overweight | 2025-10-22 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-10-22 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-10-14 |
| B of A Securities | maintain | Neutral | Neutral | 2025-10-10 |
| Mizuho | maintain | Outperform | Outperform | 2025-10-09 |
| Barclays | maintain | Overweight | Overweight | 2025-10-09 |
| Guggenheim | maintain | Buy | Buy | 2025-10-08 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-10-07 |
| UBS | maintain | Buy | Buy | 2025-09-05 |
| Barclays | maintain | Overweight | Overweight | 2025-09-04 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-08-15 |
| Baird | maintain | Neutral | Neutral | 2025-07-25 |